Jianmin Xu Selected Research

LF 57

1/2021

Decreased DNA Repair Ability: A Mechanism for Low Early Embryonic Development Potential of Oocytes From Overweight Patients After Fertilization in IVF Cycles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianmin Xu Research Topics

Disease

39	Neoplasms (Cancer) 06/2022 - 07/2006
35	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 04/2007
23	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2007
6	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2015
4	Inflammation (Inflammations) 01/2022 - 05/2011
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2012 - 05/2011
3	Rectal Neoplasms (Rectal Cancer) 01/2021 - 06/2017
3	Stomach Neoplasms (Stomach Cancer) 08/2020 - 01/2017
3	Residual Neoplasm 12/2014 - 08/2012
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 01/2020
2	Postoperative Pain 09/2021 - 07/2006
2	Pancreatitis 01/2017 - 10/2013
2	Edema (Dropsy) 01/2017 - 10/2013
2	Intra-Abdominal Hypertension 01/2017 - 10/2013
2	Breast Neoplasms (Breast Cancer) 01/2017 - 06/2011
2	Carcinoma (Carcinomatosis) 05/2016 - 04/2011
2	Rhabdomyosarcoma 06/2013 - 08/2010
2	Long QT Syndrome 08/2010 - 09/2009
1	Adenocarcinoma 01/2022
1	Anastomotic Leak 12/2021
1	Overweight 01/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021
1	Carcinogenesis 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Proteinuria 01/2020
1	Retinal Arterial Macroaneurysm 01/2019

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 04/2022 - 02/2013
9	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2006
6	Cetuximab (Erbitux)FDA Link 01/2019 - 06/2013
5	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 11/2010
4	Pharmaceutical PreparationsIBA 12/2020 - 08/2010
4	CytokinesIBA 11/2018 - 12/2011
4	Long Noncoding RNAIBA 09/2017 - 03/2015
4	Cadherins (E-Cadherin)IBA 05/2014 - 12/2008
3	Carcinoembryonic AntigenIBA 06/2022 - 10/2013
3	Biological ProductsIBA 12/2020 - 10/2018
3	RNA (Ribonucleic Acid)IBA 12/2020 - 01/2017
3	Messenger RNA (mRNA)IBA 11/2020 - 01/2018
3	Small Interfering RNA (siRNA)IBA 09/2020 - 11/2010
3	Phosphotransferases (Kinase)IBA 08/2012 - 04/2011
2	AntigensIBA 06/2022 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2020
2	Ligases (Synthetase)IBA 01/2022 - 01/2022
2	CateninsIBA 09/2020 - 01/2019
2	KH902 fusion proteinIBA 01/2020 - 01/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 06/2013
2	Leucovorin (Folinic Acid)FDA Link 01/2020 - 06/2013
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 10/2014
2	ChemokinesIBA 11/2018 - 12/2011
2	Interleukin-8 (Interleukin 8)IBA 10/2018 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 08/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2012 - 07/2011
2	VimentinIBA 08/2012 - 07/2011
2	Matrix Metalloproteinases (MMPs)IBA 08/2012 - 07/2011
2	Epidermal Growth Factor (EGF)IBA 06/2011 - 08/2008
2	Ether (Diethyl Ether)IBA 02/2011 - 08/2010
2	Contrast MediaIBA 09/2009 - 05/2009
1	regorafenibIBA 01/2022
1	Nerve Growth Factor (NGF)IBA 01/2022
1	SolutionsIBA 01/2022
1	5-methoxy-methylindoleacetic acid (DBI)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	LF 57IBA 01/2021
1	UbiquitinIBA 01/2021
1	Ubiquitin-Conjugating EnzymesIBA 09/2020
1	human ERBB2 proteinIBA 08/2020
1	honokiolIBA 08/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	SteamIBA 01/2020
1	GastrinsIBA 01/2020
1	snRNP Core ProteinsIBA 01/2020
1	Small Nuclear Ribonucleoproteins (snRNP)IBA 01/2020
1	LuciferasesIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	CarbohydratesIBA 01/2020
1	Silicone OilsIBA 01/2020
1	AmphiregulinIBA 12/2019
1	LigandsIBA 12/2019
1	Ranibizumab (Lucentis)FDA Link 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	p21-Activated KinasesIBA 01/2019
1	FilaminsIBA 01/2019

Therapy/Procedure

14	Therapeutics 04/2022 - 07/2006
13	Drug Therapy (Chemotherapy) 01/2022 - 04/2007
4	Neoadjuvant Therapy 01/2022 - 01/2014
3	Length of Stay 09/2021 - 06/2007
3	Adjuvant Chemotherapy 01/2019 - 03/2016
3	Operative Surgical Procedures 04/2016 - 07/2006
2	Colectomy 01/2021 - 01/2015
2	Continuous Renal Replacement Therapy 01/2017 - 10/2013
2	Hepatectomy 01/2014 - 04/2009
2	Enteral Nutrition (Feeding, Tube) 08/2008 - 07/2006
1	Lasers (Laser) 01/2022
1	Radiotherapy 12/2021
1	Metastasectomy 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Vitrectomy 01/2020